tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apellis price target raised to $20 from $19 at Mizuho
PremiumThe FlyApellis price target raised to $20 from $19 at Mizuho
12d ago
Apellis price target lowered to $18 from $20 at Wedbush
Premium
The Fly
Apellis price target lowered to $18 from $20 at Wedbush
13d ago
Apellis price target lowered to $18 from $20 at Wedbush
Premium
The Fly
Apellis price target lowered to $18 from $20 at Wedbush
13d ago
Apellis Pharmaceuticals: Solid Syfovre Franchise and Rapid Empaveli Uptake Underpin Buy Rating and Long-Term Upside
PremiumRatingsApellis Pharmaceuticals: Solid Syfovre Franchise and Rapid Empaveli Uptake Underpin Buy Rating and Long-Term Upside
13d ago
Apellis reports Q4 EPS 47c vs (29c) last year
Premium
The Fly
Apellis reports Q4 EPS 47c vs (29c) last year
14d ago
APLS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
APLS Earnings this Week: How Will it Perform?
16d ago
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
PremiumWeekend UpdatesApellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
1M ago
3 ‘Strong Buy’ Stocks to Buy Now, 1/21/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, 1/21/2026, According to Top Analysts
2M ago
Apellis upgraded to Buy from Neutral at BofA
Premium
The Fly
Apellis upgraded to Buy from Neutral at BofA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100